Mark Peterson

As Allegion prepares its Q2 2026 earnings, investors are weighing strong market demand against Q1's margin dip. The report will be a key signal of its future.

After 10 years of partnership, Las Vegas Sands and NPHY are moving from advocacy to action, launching a statewide plan to tackle a crisis affecting 33,000 youth.

Universal Orthodontic Lab's appointment of Dr. Ryo Hamanaka is more than a hire; it's a signal that the future of orthodontics will be won by bridging the gap between clinical science and commercial innovation.

The new OpenMP 6.1 draft isn't just a technical update; it's a direct challenge to proprietary models with grid-based programming akin to CUDA and HIP.

Capella University's partnership with the WNBA is more than a sponsorship; it's a strategic maneuver signaling a new era of athlete empowerment and brand alignment.

As the 150-year-old firm rings the NYSE bell, we dissect its journey of adaptation, middle-market dominance, and the Osaic deal that signals its next century.

A new nonprofit is using tax-exempt bonds to fight healthcare consolidation. Is Anoma Cancer Collective's model a lifeline for local cancer care?

As AI shifts from hype to essential infrastructure, a new partnership between a tech firm and an insurer shows the future: protecting computing power, not just acquiring it.

How the Danish liquorice maker leveraged a private equity buyout and a cult-like fan base to deliver 19% growth amid a global cocoa crisis.

Kinetics' new FSRU is more than a vessel; it's a power play in the global energy chess match, betting big on flexible LNG to redefine energy security.

CLOUDSUFI's new Guadalajara AI Factory is more than a nearshoring trend. It's a strategic move to industrialize AI, signaling a major shift in enterprise tech.

Private equity giant Lightyear Capital backs benefits platform Corestream, a strategic move signaling tech's pivotal role in the future of employee retention.

A Malaysian hotpot chain lands a massive data center deal, but with no tech experience and a plunging stock price, is this a brilliant pivot or a desperate gamble?

A new report shows grocers betting big on tech and health despite razor-thin profits. This isn't just survival; it's a strategic play for future market dominance.

Saol Therapeutics' NDA resubmission isn't just a second chance; it's a calculated maneuver signaling a new playbook for navigating the FDA in rare disease.

A landmark deal in Las Vegas is creating the largest direct sourcing channel for Korean goods in the U.S., signaling a fundamental shift for retailers.

While the wealth industry consolidates, one Massachusetts firm is doubling down on independence. Bartholomew & Co.'s hybrid RIA move is more than a restructure; it's a signal.

The Gprnt-SGX deal overhauls ESGenome, creating a unified digital infrastructure to streamline climate disclosures and unlock green finance opportunities.

With an instant 'A+' rating from AM Best, Capstone Specialty Insurance isn't a startup; it's a strategic play by Markel to expand its E&S market power.

A new software update from Full Swing is more than a feature refresh; it's a strategic play to democratize elite analytics and disrupt the baseball tech market.